Page 39 - Michael Erman News Today

By Aditya Samal (Reuters) - There is not sufficient evidence to recommend more than one COVID-19 booster shot a year for older people and those with w...

By Aditya Samal (Reuters) - There is not sufficient evidence to recommend more than one COVID-19 booster shot a year for older people and those with w...

By Michael Erman NEW YORK (Reuters) - U.S. Senator Elizabeth Warren has sent the nation's top patent regulator a letter urging close scrutiny of Merck...

By Patrick Wingrove and Michael Erman (Reuters) - Moderna Inc on Thursday said its experimental messenger RNA-based influenza vaccine generated a stro...

By Michael Erman and Patrick Wingrove

Gilead Sciences Inc on Thursday reported a higher-than-expected fourth-quarter profit driven by strong demand for its HIV and cancer drugs, while COVID-19 antiviral Veklury had sales that were... | February 2, 2023

By Michael Erman (Reuters) - Drugmaker Bristol Myers Squibb said on Thursday its fourth quarter sales and earnings had fallen, hurt by lower sales of ...

Amgen Inc on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments... | February 1, 2023

Pfizer on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products as governments cut orders and work through inventories.

By Manas Mishra and Michael Erman (Reuters) - Clarity from Pfizer Inc this week on whether China's relaxation of its Zero-COVID policy and the surge i...